DFS and OS by treatment arm for the intermediate cytogenetic risk group. (A) Predicted 5-year DFS was 38% for the HiDAC group (n = 242; red line) and 39% for the multiagent CT group (n = 256; blue line; P = .403). (B) Predicted 5-year OS was 53% for the HiDAC group (n = 242; red line) and 54% for the multiagent CT group (n = 256; blue line; P = .482).